Login / Signup

FGF-21: a novel biomarker predicting no-reflow in ST-segment elevation myocardial infarction.

D KopruluK ToprakG Genc TaparM Ocak
Published in: European review for medical and pharmacological sciences (2024)
Our study demonstrates a strong association between the NR phenomenon, a key indicator of poor prognosis in acute STEMI patients, and an elevated FGF-21 level. These findings indicate FGF-21 as a novel and potent predictor of NR development in STEMI patients.
Keyphrases